| 1 |
An Evidence-Based Retrospective Study for the Management of Acid Peptic Disease With Omeprazole, a Proton Pump Inhibitor, in Indian Patients With Type 2 Diabetes Mellitus (PRIDE-1) |
|
| | Bharat Saboo, Nimmi Mulwani, Anup U Petare, Krishna C Veligandla, Colette S Pinto, Amey Mane, Rahul Rathod, Bhavesh Kotak | | | Cureus. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Autophagy blockade mechanistically links proton pump inhibitors to worsened diabetic nephropathy and aborts the renoprotection of metformin/enalapril |
|
| | Dalia Kamal Mostafa,Mohamed Mostafa Khedr,Mervat Kamel Barakat,Amany Abdelbary Abdellatif,Amal Mohamed Elsharkawy | | | Life Sciences. 2021; 265: 118818 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-Analysis |
|
| | Carol Chiung-Hui Peng,Yu-Kang Tu,Gin Yi Lee,Rachel Huai-En Chang,Yuting Huang,Khulood Bukhari,Yao-Chou Tsai,Yunting Fu,Huei-Kai Huang,Kashif M Munir | | | The Journal of Clinical Endocrinology & Metabolism. 2021; | | | [Pubmed] [Google Scholar] [DOI] | |
|
